title: Implementing pharmacoeconomic guidelines in Latin America: lessons learned.
authors.affiliation: Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias/Economic Evaluations, Universidad de Buenos Aires, Argentina.
authors.forename: Federico
authors.initials: F
authors.lastname: Augustovski
authors.forename: Guillermo
authors.initials: G
authors.lastname: Melendez
authors.forename: Alexandre
authors.initials: A
authors.lastname: Lemgruber
authors.forename: Michael
authors.initials: M
authors.lastname: Drummond
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence; D033161:Government Regulation; D019983:Guideline Adherence; D017048:Health Care Costs / Q000331:legislation & jurisprudence; D015276:Health Care Rationing / Q000191:economics* / Q000331:legislation & jurisprudence; D006291:Health Policy; D006297:Health Services Accessibility / Q000191:economics; D006302:Health Services Research; D054625:Healthcare Disparities / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007843:Latin America; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence; D010043:Outcome and Process Assessment, Health Care / Q000191:economics* / Q000331:legislation & jurisprudence; D017410:Practice Guidelines as Topic